Breakout stock

 TOWER TALK 29/11/22 

 SPIC (Southern Petrochemicals), a $2 billion Muthiah group fertilizer conglomerate posted 85% higher Q2 EPS of Rs 5.7 and 88% higher H1 EPS of Rs 9.2 as against Rs 8.8 in FY22. This indicates that FY23 EPS could be Rs 19+. Buy for 30% gain.

 GSFC (Gujarat State Fertilizers) has notched 24% higher Q2 EPS of Rs 7.2 (FV Rs 2) and 72% higher H1 EPS of Rs 15.8, which may result in FY23 EPS of Rs 30 as against Rs 22.6 in FY22. Buy for steady appreciation.

 Cash rich Seshasayee Paper has garnered 285% higher Q2 EPS of Rs 17.7 and H1 EPS of Rs 27.7 as against FY22 EPS of Rs 18.3. This could take the FY23 EPS to about Rs 60. Buy for 30% gain. 
 Karnataka Bank has notched 230% higher Q2 EPS of Rs 13.2 and 128% higher H1 EPS of Rs 16.9, which indicates that FY23 EPS may be Rs 35+. Buy for a target of over Rs 180.

 Jammu & Kashmir Bank posted 124% higher Q2 EPS of Rs 2.5 and H1 EPS of Rs 4.2, which indicates that FY23 EPS could be Rs 10 against FY22 EPS of Rs 6. The share may fetch a gain of 40%. Buy.

 Voith Paper Fabrics (formerly Porrits & Spencer), a German MNC with 74% equity stake has posted 22% higher Q2 EPS of Rs 17.4 and 5% higher H1 EPS of Rs 34, which may lead to FY23 EPS of Rs 72. Buy for 25% gain.@mwglobal

 Canara Bank has clocked a 94% higher Q2 EPS of Rs 14.9 and 77% higher H1 EPS of Rs 26.9 as against FY22 EPS of Rs 32.5. A likely FY23 EPS of Rs 55 may fetch a cool gain of 30%. Buy.

 Titan Bio posted 43% higher Q2 EPS of Rs 11 and 9% higher H1 EPS of Rs 20.1, which may take FY23 EPS to Rs 35 as against Rs 30.7 in FY22. Add.

 DCB Bank posted 112% higher H1 net profit of Rs.209.50 cr. v/s Rs. 98.70 cr. in H1FY22. Its NPAs & provisioning have also drastically reduced and may have more surprises for investors. Buy for good returns in short to medium term.

 MNC Accelya Solutions India is a leading global provider of technology platforms, software & services to the travel & transport industry. It posted Q2 net profit of Rs.33.11 cr. v/s Rs.25.17 cr. last year. Buy for very good returns in the short to medium term.

 Ind-Swift Lab posted H1 PAT of Rs.45.22 cr. on its equity of Rs.59.08 cr. leading to an EPS of Rs 7.65 in 6 months. Available at PE of only 4. Keep on your radar.

 RCF posted 73% higher H1 net profit of Rs.562 cr. v/s Rs.325 cr. in H1FY22. Its board meeting is scheduled on 29th November to consider declaration of Interim dividend. Keep on your radar.